SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001683168-19-003022
Filing Date
2019-09-23
Accepted
2019-09-23 15:42:29
Documents
7

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 5963
2 PART II AND III cbd_1aa2-poc.htm PART II AND III 1377936
3 OPINION OF COUNSEL cbd_ex1201.htm EX1A-12 OPN CNSL 6575
4 GRAPHIC logo.jpg GRAPHIC 34896
5 GRAPHIC image_001.jpg GRAPHIC 9809
6 GRAPHIC image_002.jpg GRAPHIC 2543
7 GRAPHIC image_005.jpg GRAPHIC 3173
  Complete submission text file 0001683168-19-003022.txt   1461538
Mailing Address 11445 E. VIA LINDA, UNIT 2-496 SCOTTSDALE AZ 85259
Business Address 11445 E. VIA LINDA, UNIT 2-496 SCOTTSDALE AZ 85259 480-776-0281
CBD Life Sciences Inc. (Filer) CIK: 0001776073 (see all company filings)

IRS No.: 205118532 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 1-A/A | Act: 33 | File No.: 024-11005 | Film No.: 191107965
SIC: 2833 Medicinal Chemicals & Botanical Products